Get the Stockscreener App
68.05
1.52%
1.02
Doximity Inc stock is traded at $68.05, with a volume of 822.10K.
It is up +1.52% in the last 24 hours and down -6.10% over the past month.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
See More
Previous Close:
$67.03
Open:
$67.83
24h Volume:
822.10K
Relative Volume:
0.55
Market Cap:
$9.28B
Revenue:
$550.17M
Net Income/Loss:
$201.35M
P/E Ratio:
68.05
EPS:
1
Net Cash Flow:
$232.07M
1W Performance:
-7.45%
1M Performance:
-6.10%
6M Performance:
+27.84%
1Y Performance:
+55.15%
1-Day Range:
$67.24
$68.91
1-Week Range:
$65.58
$73.53
52-Week Range:
$40.87
$85.21
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
68.05 | 12.55B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
287.38 | 47.15B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
91.91 | 15.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
92.55 | 8.10B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.73 | 6.99B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-10-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-25 | Downgrade | Goldman | Neutral → Sell |
| Jul-09-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jun-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-07-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-09-24 | Upgrade | Needham | Hold → Buy |
| Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-09-23 | Downgrade | Needham | Buy → Hold |
| Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-31-22 | Initiated | Wells Fargo | Overweight |
| Oct-24-22 | Initiated | Evercore ISI | In-line |
| Oct-13-22 | Initiated | BTIG Research | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-28-22 | Initiated | Berenberg | Buy |
| May-18-22 | Reiterated | BofA Securities | Neutral |
| May-18-22 | Reiterated | Goldman | Buy |
| May-18-22 | Reiterated | Guggenheim | Buy |
| May-18-22 | Reiterated | Jefferies | Buy |
| May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
| May-18-22 | Reiterated | Needham | Buy |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-04-22 | Initiated | BofA Securities | Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-21 | Reiterated | Goldman | Neutral |
| Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Nov-10-21 | Reiterated | Needham | Buy |
| Nov-10-21 | Reiterated | Piper Sandler | Overweight |
| Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-19-21 | Initiated | Canaccord Genuity | Buy |
| Jul-19-21 | Initiated | Goldman | Neutral |
| Jul-19-21 | Initiated | JP Morgan | Overweight |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | Raymond James | Outperform |
| Jul-19-21 | Initiated | SVB Leerink | Outperform |
| Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
Doximity (NASDAQ:DOCS) Director Sells $354,200.00 in Stock - MarketBeat
Exit strategy if you’re trapped in Doximity Inc.Trade Performance Summary & Low Drawdown Investment Ideas - newser.com
Will Doximity Inc. stock recover faster than peersRate Hike & Weekly High Conviction Ideas - newser.com
Key metrics from Doximity Inc.’s quarterly dataTrade Analysis Report & Daily Growth Stock Investment Tips - newser.com
Is Doximity Inc. trending in predictive chart modelsWeekly Stock Recap & Real-Time Volume Surge Alerts - newser.com
Will earnings trigger a reversal in Doximity Inc.July 2025 Catalysts & Growth Focused Entry Point Reports - newser.com
Will Doximity Inc. Class stock announce a stock splitPrice Action & Risk Managed Investment Signals - newser.com
Using AI based signals to follow Doximity Inc.Weekly Investment Report & Precise Swing Trade Entry Alerts - newser.com
What catalysts could drive Doximity Inc. stock higherChart Signals & Stepwise Swing Trade Plans - newser.com
Does Doximity Inc. qualify in momentum factor screening2025 Price Action Summary & Momentum Based Trading Ideas - newser.com
Can machine learning forecast Doximity Inc. recoveryJuly 2025 Closing Moves & Safe Capital Growth Stock Tips - newser.com
How to read the order book for Doximity Inc.Quarterly Market Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Is Doximity Inc. stock attractive for hedge funds2025 Price Momentum & Reliable Entry Point Trade Alerts - newser.com
ZoomInfo, Upstart, F5, Procore Technologies, and Doximity Shares Skyrocket, What You Need To Know - The Globe and Mail
Doximity’s SWOT analysis: digital health leader faces valuation hurdles By Investing.com - Investing.com Australia
Doximity’s SWOT analysis: digital health leader faces valuation hurdles - Investing.com India
Why Doximity Inc. Class stock appears on watchlistsWeekly Stock Recap & High Accuracy Buy Signal Tips - newser.com
Doximity, Inc. (DOCS) Stock Analysis: Understanding the 6.86% Potential Upside for Investors - DirectorsTalk Interviews
Doximity (DOCS): 3 Reasons We Love This Stock - The Globe and Mail
Applying sector rotation models to Doximity Inc.2025 Volatility Report & Fast Exit and Entry Trade Guides - newser.com
How to recover losses in Doximity Inc. stockPortfolio Return Summary & Daily Entry Point Trade Alerts - newser.com
Will Doximity Inc. Class stock beat growth indexesWeekly Market Report & Free High Return Stock Watch Alerts - newser.com
Doximity (NASDAQ:DOCS) Stock Price Down 5%Should You Sell? - MarketBeat
Doximity (DOCS) Valuation: Weighing Long-Term Gains Against Recent Share Price Drop - Yahoo Finance
Doximity's (DOCS) Underweight Rating Reiterated at JPMorgan Chase & Co. - MarketBeat
Doximity, Inc. $DOCS Shares Sold by Lmcg Investments LLC - MarketBeat
Here's Why Doximity (DOCS) Fell More Than Broader Market - sharewise.com
Doximity Shares Fall After Downgrade From JPMorgan - MarketScreener
Why Doximity (DOCS) Shares Are Trading Lower Today - Yahoo Finance
Doximity downgraded at J.P. Morgan on valuation and advertising concerns - MSN
When is the best time to exit Doximity Inc.Weekly Risk Summary & Step-by-Step Trade Execution Guides - newser.com
This Keysight Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga
JPMorgan Downgrades Doximity to Underweight From Neutral, $62 Price Target - MarketScreener
JPMorgan downgrades Doximity stock to Underweight on valuation concerns By Investing.com - Investing.com Australia
JPMorgan downgrades Doximity stock to Underweight on valuation concerns - Investing.com
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.58%
0.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):